Chemo Pharma Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Chemo Pharma Laboratories Ltd. on BSE

Search Inside the pdf :

Chemo Pharma Laboratories Ltd.

29 Aug 2025

123.40

-1.00%

Company Update

Chemo Pharma Laboratories Ltd - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of notice for attention of Equity Shareholders of the Company in respect of information regarding 83rd Annual General Meeting to be held on 24th September, 2025 through video conferencing (VC) / Other Audio-Visual Means (OAVM).

pdf

Chemo Pharma Laboratories Ltd.

28 Aug 2025

123.40

-1.00%

AGM

Chemo Pharma Laboratories Ltd - 506365 - Notice Of 83Rd AGM Scheduled On 24Th September, 2025

BSE India

Notice of 83rd AGM scheduled on 24th September, 2025

pdf

Chemo Pharma Laboratories Ltd.

28 Aug 2025

123.40

-1.00%

Corp. Note

Chemo Pharma Laboratories Ltd - 506365 - Reg. 34 (1) Annual Report.

BSE India

Annual Report FY 2024-25

pdf

Chemo Pharma Laboratories Ltd.

27 Aug 2025

123.40

-1.00%

Company Update

Chemo Pharma Laboratories Ltd - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of Newspaper Advertisements for attention of Equity Shareholders of the Company in respect of information regarding 83rd Annual General Meeting to be held on 24th September, 2025 through Video Conferencing (VC) / Other Audio Visual Means (OAVM).

pdf

Chemo Pharma Laboratories Ltd.

22 Aug 2025

123.40

-1.00%

Board Meeting

Chemo Pharma Laboratories Ltd - 506365 - Board Meeting Outcome for Intimation Under Regulation 31A Of …

BSE India

Board approved Reclassification request received to change the status from Promoter Group Shareholder to Public Shareholder

pdf

Chemo Pharma Laboratories Ltd.

14 Aug 2025

123.40

-1.00%

Board Meeting

Chemo Pharma Laboratories Ltd - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To …

BSE India

Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2025 ,inter alia, to consider and approve the request letter dated 11th August, 2025 received for reclassification of the status by Ms. Shanta Somani from 'Promoter Group Shareholder' to 'Public Shareholder' pursuant to Regulation 31A of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 subject to the requisite approvals from the Stock exchanges and any other necessary approval(s).

pdf

Chemo Pharma Laboratories Ltd.

14 Aug 2025

123.40

-1.00%

Company Update

Chemo Pharma Laboratories Ltd - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Submission of Newspaper Advertisement of Unaudited Financial Results for the First Quarter Ended June 30, 2025 of the Company.

pdf

Chemo Pharma Laboratories Ltd.

12 Aug 2025

123.40

-1.00%

Corp. Action

Chemo Pharma Laboratories Ltd - 506365 - Intimation Of Book Closure And Record Date For The …

BSE India

Intimation of Book Closure to the Regulation 42(2) to 42(4) of SEBI (LODR) Regulations, 2015.

pdf

Chemo Pharma Laboratories Ltd.

12 Aug 2025

123.40

-1.00%

Result

Chemo Pharma Laboratories Ltd - 506365 - Submission Of Un-Audited Financial Results For The Quarter Ended …

BSE India

Approval of Un-Audited Financial Results of the Company for the Quarter ended June 30, 2025 along with the Limited Review Report thereon.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.02	-0.16	0.30	112.5%	-93.3%
Operating Profit Qtr	-11.83	-0.02	-0.05	-59050.0%	-23560.0%
Net Profit Qtr	-11.81	-0.34	0.25	-3373.5%	-4824.0%
Earning Per Share Adjusted latest Qtr	-78.70	-2.26	1.64	-3382.3%	-4898.8%

* Standalone data

Detailed Results

Chemo Pharma Laboratories Ltd.

12 Aug 2025

123.40

-1.00%

Board Meeting

Chemo Pharma Laboratories Ltd - 506365 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

Board of Directors of the Company at their meeting held on Tuesday, August 12, 2025 , have discussed the following matters: 1. Approved the Un-Audited Financial Results of the Company for the quarter ended June 30, 2025 along with the Limited Review Report thereon. 2. Approved the Notice of the 83rd Annual General Meeting of the members of the Company to be held on Wednesday, 24th September, 2025 at 4:00 P.M. for the year ended March 31, 2025. 3. Approved the Book Closure date. 4. Decided to change of Name of the Company. 5. Decided to consider the the Main Object of the Company & alteration in Object Clause of Memorandum of Association of the Company 6. Decided to shift the Registered Office of the Company from the State of Maharashtra (Kalyan) to State of Gujarat (Ahmedabad). 7. Appointment of Scrutinizer for E-Voting at the forthcoming 83rd Annual General Meeting of the Company.

pdf

Is Chemo Pharma Laboratories Ltd. worth buying?

7 Votes:

Buy 28.57%

Sell 14.29%

Hold 57.14%